# Curcumin and Retinal Study

> **NCT05774704** · PHASE1,PHASE2 · RECRUITING · sponsor: **Texas Tech University Health Sciences Center** · enrollment: 60 (estimated)

## Conditions studied

- Bioavailability
- Gut Microbiome
- Safety

## Interventions

- **DRUG:** Low curcumin group
- **DRUG:** High curcumin group

## Key facts

- **NCT ID:** NCT05774704
- **Lead sponsor:** Texas Tech University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-21
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05774704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05774704, "Curcumin and Retinal Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05774704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*